Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
The British Journal of Oral & Maxillofacial Surgery|November 1, 2019
Tranexamic acid to reduce bleeding after dental extraction in patients treated with non-vitamin K oral anticoagulants: design and rationale of the EXTRACT-NOAC trialA Ockerman, M Vanhaverbeke, I Miclotte, et al.Clinical Radiology|October 8, 2023
Direct puncture versus contralateral femoral artery approach for catheter-directed thrombolysis of occluded infra-inguinal arterial bypass graftsH Verelst, L Bonne, H Mufty, et al.Journal of Thrombosis and Haemostasis : JTH|February 3, 2011
Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trialP Verhamme, M Tangelder, R Verhaeghe, et al.Journal of Thrombosis and Haemostasis : JTH|December 2, 2017
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for cliniciansJ Douxfils, W Ageno, C-M Samama, et al.Journal of Thrombosis and Haemostasis : JTH|November 2, 2011
Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulenceT Vanassche, J Verhaegen, W E Peetermans, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
Circulating oxidized LDL is a useful marker for identifying patients with coronary artery diseaseP Holvoet, A Mertens, P Verhamme, et al.Journal of Thrombosis and Haemostasis : JTH|May 1, 2012
Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIIIM Tangelder, C Long, J Emmerechts, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 21, 2007
Major coagulation disturbances during fractionated plasma separation and adsorptionB K I Meijers, P Verhamme, F Nevens, et al.International Journal of Laboratory Hematology|March 25, 2018
The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assaysM Jacquemin, J Toelen, L Feyen, et al.Thrombosis Research|July 23, 2011
Partial versus complete factor VIII inhibition in a mouse model of venous thrombosisJ Emmerechts, T Vanassche, S Loyen, et al.Pageof 5